share_log

Cantor Fitzgerald Reiterates Overweight on Connect Biopharma Hldgs, Maintains $5 Price Target

Benzinga ·  Sep 13, 2023 08:24

Cantor Fitzgerald analyst Louise Chen reiterates Connect Biopharma Hldgs (NASDAQ:CNTB) with a Overweight and maintains $5 price target.

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment